http://www.hepatitis-central.com/mt/ Hepatitis C News, Updates and Commentary. Copyright 2012 Wed, 16 May 2012 10:07:03 -0500 http://www.movabletype.org/?v=4.25 http://blogs.law.harvard.edu/tech/rss Two vitamins and the universal antioxidant may be able to interfere with the acceleration of cellular damage in those with both Hepatitis C and COPD. http://www.hepatitis-central.com/mt/archives/2012/05/concurrent_hepa.html http://www.hepatitis-central.com/mt/archives/2012/05/concurrent_hepa.html Complementary/Alternative Therapies Wed, 16 May 2012 10:07:03 -0500 In just three weeks, the Hepatitis C drug in development, GS-7977, led to a sustained virologic response in over 90 percent of patients when paired with ribavirin and pegylated interferon. http://www.hepatitis-central.com/mt/archives/2012/05/triple_therapy_1.html http://www.hepatitis-central.com/mt/archives/2012/05/triple_therapy_1.html Emerging Hepatitis C Treatments/Therapies Mon, 07 May 2012 14:55:39 -0500 Of concern to those co-infected with Hepatitis C and HIV, the FDA has confirmed that the Hep C drug, boceprevir, interferes with the HIV drug, ritonavir. http://www.hepatitis-central.com/mt/archives/2012/05/boceprevir_and.html http://www.hepatitis-central.com/mt/archives/2012/05/boceprevir_and.html General Hepatitis C News/Updates Tue, 01 May 2012 15:06:11 -0500 To assist with drug safety in the presence of Hepatitis C infection, patients are urged to take an active role in managing their medications. http://www.hepatitis-central.com/mt/archives/2012/04/hep_c_bulletin.html http://www.hepatitis-central.com/mt/archives/2012/04/hep_c_bulletin.html Understanding HCV Mon, 30 Apr 2012 10:17:06 -0500 Treatment naïve patients with Hepatitis C genotype 1 boasted a 100 percent success rate when given Gilead's GS-7977 and Bristol-Myers Squibb's daclatasvir. http://www.hepatitis-central.com/mt/archives/2012/04/hep_c_trial_of.html http://www.hepatitis-central.com/mt/archives/2012/04/hep_c_trial_of.html Emerging Hepatitis C Treatments/Therapies Tue, 24 Apr 2012 10:32:12 -0500 Boehringer Ingelheim's all oral Hepatitis C drugs cured 82 percent of patients with the most common type of Hepatitis C in mid-stage trials. In addition, these drugs exhibited the potential to cure people with cirrhosis. http://www.hepatitis-central.com/mt/archives/2012/04/trial_claims_fi.html http://www.hepatitis-central.com/mt/archives/2012/04/trial_claims_fi.html Emerging Hepatitis C Treatments/Therapies Mon, 23 Apr 2012 16:28:35 -0500 Quercetin is a relative newcomer to the arsenal of nutritional supplements believed to help those with Hepatitis C. http://www.hepatitis-central.com/mt/archives/2012/04/quercetin_might.html http://www.hepatitis-central.com/mt/archives/2012/04/quercetin_might.html Complementary/Alternative Therapies Tue, 17 Apr 2012 10:13:18 -0500 SST (Sho-saiko-to) is made up of seven medicinal plants which, when used together, help to build immunity and stabilize liver health. Learn more about the benefits of SST, and why it was temporarily unavailable until just recently. http://www.hepatitis-central.com/mt/archives/2012/04/the_all_natural.html http://www.hepatitis-central.com/mt/archives/2012/04/the_all_natural.html General Hepatitis C News/Updates Thu, 12 Apr 2012 11:11:53 -0500 A combination of oral drugs - ribavirin and two of Abbott's drugs in development - demonstrated unprecedented Hepatitis C cure rates in a small, mid-stage study. http://www.hepatitis-central.com/mt/archives/2012/04/oral_hep_c_trio.html http://www.hepatitis-central.com/mt/archives/2012/04/oral_hep_c_trio.html Emerging Hepatitis C Treatments/Therapies Tue, 10 Apr 2012 15:20:52 -0500 Using an approach called exhaustive panning, Scripps researchers have advanced the search for a Hepatitis C vaccine by identifying the antibody AR4A. http://www.hepatitis-central.com/mt/archives/2012/04/scripps_finds_a.html http://www.hepatitis-central.com/mt/archives/2012/04/scripps_finds_a.html Emerging Hepatitis C Treatments/Therapies Mon, 09 Apr 2012 10:36:11 -0500 The stigma surrounding addiction may discourage Hepatitis C treatment for drug users - but the evidence encourages these individuals to do triple therapy. http://www.hepatitis-central.com/mt/archives/2012/03/hepatitis_c_tre_4.html http://www.hepatitis-central.com/mt/archives/2012/03/hepatitis_c_tre_4.html General Hepatitis C News/Updates Fri, 23 Mar 2012 08:26:26 -0500 The individual who first identified the Hepatitis C virus might be the same person responsible for ending its infectious reign. http://www.hepatitis-central.com/mt/archives/2012/03/hcv_discovery_a.html http://www.hepatitis-central.com/mt/archives/2012/03/hcv_discovery_a.html General Hepatitis C News/Updates Thu, 22 Mar 2012 09:44:50 -0500 By delivering genetic material to initiate a T cell response, Okairos is looking to create the first Hepatitis C preventative vaccine. http://www.hepatitis-central.com/mt/archives/2012/03/new_hep_c_vacci.html http://www.hepatitis-central.com/mt/archives/2012/03/new_hep_c_vacci.html Emerging Hepatitis C Treatments/Therapies Thu, 22 Mar 2012 09:35:26 -0500 Boasting the world's highest rate of Hepatitis C, Egypt has a lot to gain from the American University in Cairo's fast and inexpensive Hepatitis C test. http://www.hepatitis-central.com/mt/archives/2012/03/egyptian_hep_c.html http://www.hepatitis-central.com/mt/archives/2012/03/egyptian_hep_c.html General Hepatitis C News/Updates Wed, 14 Mar 2012 08:17:49 -0500 In two separate Phase 3 trials, Hepatitis C patients with genotypes 1 and 4 are being treated with TMC435 plus pegylated interferon and ribavirin. http://www.hepatitis-central.com/mt/archives/2012/03/hepatitis_c_pha.html http://www.hepatitis-central.com/mt/archives/2012/03/hepatitis_c_pha.html Emerging Hepatitis C Treatments/Therapies Tue, 13 Mar 2012 16:52:53 -0500